[1]
Saad Muzaffar Azeem et al. 2026. OPTIMIZING AMINOGLYCOSIDE DOSING IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE PATIENTS UNDERGOING INTERMITTENT HEMODIALYSIS: CARDIOVASCULAR IMPLICATIONS AND CLINICAL OUTCOMES. Journal of Population Therapeutics and Clinical Pharmacology. 33, 2 (Jul. 2026), 1139–1149. DOI:https://doi.org/10.69980/bn50yg38.